Preclinical research struggles with limitations that hinder progress. In this webinar, Professor Kalaskar, from the Department of Ortho and MSK Science, will explain how bioprinting technology could address these challenges and offer a game-changing solution. He will present how bioprinting can revolutionise the field by showcasing specific innovations developed by his team. The seminar will conclude with insights on the evolving regulatory landscape, including a discussion on the FDA Modernization Act 2 and its potential impact on future pre-clinical and clinical research.
20
7/17/2024
In this presentation, Prof. Thalassinos from the Institute of Structural and Molecular Biology explored the functionalities of the UCL Mass Spectrometry Science Technology Platform, focusing on its mass spectrometry capabilities. He will also highlight several recent research projects that have been made possible due to this remarkable technology.
This is part of the webinar series by the UCL Therapeutic Innovation Networks (TINs) to highlight UCL’s Research Infrastructure and Capabilities that enable effective translation of products toward patient/public benefit. The series aims to encourage multidisciplinary collaborations across departments. Academics from the UCL biomedical community are invited to share subjects of interest from their research expertise and interact with research fellows.
8
5/23/2024
Electron microscopy (EM) provides ultrastructural information at nanometre resolution which, when combined with a wide variety of sample preparation techniques and multimodal approaches, can be an exceptionally powerful research tool. With continual advances being made, and for example volume EM being named by Nature as “One of the seven technologies to watch in 2023”, Jemima Burden, Head of Electron Microscopy at the Laboratory for Molecular Cell Biology, will share some of the approaches available to address research questions related to basic cell and developmental biology, through to virology, immunology, neurodegenerative diseases, regeneration, cancer biology and drug and therapeutic development.
This is part of the webinar series by the UCL Therapeutic Innovation Networks (TINs) to highlight UCL’s Research Infrastructure and Capabilities that enable effective translation of products toward patient/public benefit.
10
4/15/2024
This special two-part seminar delves into innovative approaches to treatment, highlighting the value of in vitro models in advancing healthcare.
Part 1: Dr Lucy Granat from the Alzheimer's Research UK UCL Drug Discovery Institute will discuss their use of in vitro models in understanding neurodegenerative diseases. This includes validating new drug targets and developing new treatments, ultimately aiming to accelerate progress in tackling these challenging conditions.
Part 2: Dr Mattia Gerli, from the Division of Surgery and Interventional Science, will present recent research on generating primary organoid models using amniotic and tracheal fluids. This holds immense potential for personalised regenerative medicine tailored to the foetus.
This is part of the webinar series by the UCL Therapeutic Innovation Networks (TINs) to highlight UCL’s Research Infrastructure and Capabilities that enable effective translation of products toward patient/public benefit. The series aims to encoura
15
3/21/2024
(Note: the webinar finishes at timecode 50:00)
In this webinar, Dr Darren Nesbeth, a synthetic biologist at the UCL Biochemical Engineering Department, explored the daunting technical challenges faced by the nascent cultivated meat industry and also the opportunities for researchers in regenerative medicine, and other fields, to come together and develop the innovations that will pave the way to a more sustainable food future.
68
2/23/2024
During this webinar, Prof. Umber Cheema from the Department of Targeted Intervention will delve into how bioengineered tumoroids for colorectal, renal, and osteosarcoma tumours, incorporating connective tissue stroma and bone stroma, exhibit distinct hallmarks of tumour progression. These tumoroids provide quantifiable data to assess drug efficacy and hold the potential, if further developed, to replace animal studies in the early stages of therapeutic intervention testing.
13
1/25/2024
This video highlights the work of 2020 Regenerative Medicine TIN PDS awardee Dr Hassan Rashidi, with a project titled “Dissecting the cross-talk between parenchymal and non-parenchymal derivatives within human pluripotent stem cell-derived 3D hepatospheres (3D Heps) using spatial transcriptomics”.
Hassan comments on the importance of basic science in the translational pathway.
The next Pilot Data Scheme funding opportunity for the Repurposing TIN is now open for applications until 24th October 2021. Learn more and apply: https://www.ucl.ac.uk/therapeutic-innovation-networks/funding-opportunities
191
10/22/2021
Agenda:
12:30-12:35 – Welcome and introduction of the TINs (Asha Recino, Therapeutic Innovations Networks Coordinator)
12:35-12:45 – Patient and Public Involvement (PPI) in Research - An introduction (Linda von Nerée, PPI Lead at NIHR Blood and Transplant Research Unit (BTRU) in Stem Cells and Immunotherapies at UCL)
12:45-12:55– PPI engagement and benefits in gene therapy research (Matthew Walker, Consultant Neurologist at the National Hospital for Neurology and Neurosurgery)
12:55 -13:05 – Patient experience and involvement in hemophilia gene therapy studies (Luke Pembroke, Gene Therapy Patient)
13:05 -13:15 – Patient involvement in stem cell and immunotherapies for blood cancer (Gillian Murphy, Patient & Public Research Panel Member, Blood and Transplant Research Unit at UCL)
13:15- 13:25 – PPI in pre-clinical regenerative medicine research (Nick Hamilton, NIHR Clinical Lecturer, UCL)
https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
88
4/30/2021